Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Immunotherapy in older patients

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 23.11.18
Views: 327

Dr Ellen Kapiteijn - Universiteit Leiden, Leiden, The Netherlands

Dr Ellen Kapiteijn speaks to ecancer at the International Society of Geriatric Oncology 2018 conference in Amsterdam about the efficacy of immunotherapy in older patients.

Dr Kapiteijn explains that immunotherapy with checkpoint inhibitors is as efficacious as it is with younger patients, so older patients should not be excluded from this treatment.

She also highlights that the immune function of older patients cannot be predicted by looking at immunosenescence alone - an area she hopes to present more on in the future.

This service has been kindly supported by an unrestricted grant from Janssen Oncology.
 

Related videos

follow us

Donate to ecancer


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation